ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1268

Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Comparison of Machine Learning Methods

Melissa Fazzari1, Marta Guerra2, Jane Salmon2 and Mimi Kim3, 1Albert Einstein College of Medicine, Bronx, NY, 2Hospital for Special Surgery, New York, NY, 3Albert Einstein College of Medicine, Larchmont, NY

Meeting: ACR Convergence 2021

Keywords: Biostatistics, health status, Outcome measures, pregnancy, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Outcomes (1257–1303)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Nearly 20% of pregnancies in patients with Systemic lupus erythematosus (SLE) result in an adverse pregnancy outcome (APO); early identification of women with SLE who are at high risk of APO is vital. We previously derived a risk model for APO using logistic regression and data from the PROMISSE Study, a large multi-center, multi-ethnic/racial study of APO in women with mild/moderate SLE and/or aPL. While this highly interpretable regression model showed promising predictive performance, we sought to determine if novel and increasingly popular machine learning (ML) approaches would enhance APO risk prediction using all available predictors and potential complex relationships such as interactions or higher order terms. We compared logistic regression modeling to LASSO, a regression approach that handles high-dimensionality and correlated predictors through shrinkage of estimated coefficients, as well as several “black box” ML algorithms. ML techniques are well-suited to high-dimensional data, require no variable selection, and unlike regression-based approaches are able to explore complex relationships without explicit input by the user.

Methods: We used the original PROMISSE data (41 predictor variables from 385 subjects) with APO (71/385, 18.4%) defined as preterm delivery due to placental insufficiency or preeclampsia, fetal or neonatal death, or fetal growth restriction. Logistic regression with stepwise selection (LR-S) was compared to LASSO, random forest (RF), neural network (NN) with 2 hidden neurons, support vector machines with RBF kernel (SVMRBF), and gradient boosting (GB). To summarize discrimination we present cross-validated area under the receiver operating curve (AUC), along with sensitivity (Sn) and specificity (Sp) at an optimal cut-point.

Results: Regression based classifiers confirmed the predictors of APO identified in our previously reported model: non-white race, use of anti-hypertensive medication, low platelets, SLE disease activity, lupus anticoagulant (LAC) +, and high diastolic blood pressure (DBP). RF additionally revealed two novel interaction variables that increased APO risk: LAC+ with anti-b2GPI IgM, high DBP with low C3. LR-S and LASSO were observed to have similar overall discrimination (AUC=0.75 vs. 0.77) but LASSO had higher sensitivity (Sn=0.71 vs. 0.65). ML classifiers RF and SVMRBF had similar good performance (AUC=0.77-0.78), while NN and GB were inferior.

Conclusion: Several popular ML algorithms did not provide meaningful improvements to the previously identified model for APO prediction. The strong relative performance of regression-based models with this large and well-characterized clinical data set is notable as these models are highly interpretable, well-understood, and generally require fewer variables to generate a risk prediction. New clinical and laboratory markers may improve predictions in the future.


Disclosures: M. Fazzari, None; M. Guerra, None; J. Salmon, UCB, 1, 5, BMS, 1, Aurinia, 1; M. Kim, None.

To cite this abstract in AMA style:

Fazzari M, Guerra M, Salmon J, Kim M. Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Comparison of Machine Learning Methods [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/predicting-adverse-pregnancy-outcomes-in-women-with-systemic-lupus-erythematosus-a-comparison-of-machine-learning-methods/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predicting-adverse-pregnancy-outcomes-in-women-with-systemic-lupus-erythematosus-a-comparison-of-machine-learning-methods/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology